Clinical Trial Update: Pulmonary Hypertension: Assessment of Cell Therapy [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed a cell therapy for pulmonary hypertension and has completed, though no efficacy results are detailed in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Northern Therapeutics | Conditions: Hypertension, Pulmonary | Phase 1 | Status: COMPLETED